Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 4, 2003, Pages 861-863

  Chatterjee, T ^a   Schroeder, V ^b   Windecker, S ^a   Meier, B ^a   Kohler, H P ^b  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; PROTEIN SUBUNIT;

BLOOD; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; HUMAN; LETTER; PREDICTION AND FORECASTING; VEIN;

CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FACTOR VIII; HUMANS; PREDICTIVE VALUE OF TESTS; PROTEIN SUBUNITS; VEINS;

EID: 0142166251     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.t01-8-00115.x     Document Type: Letter

References (13)

1. Kohler HP, Stickland MH, Ossei-Gerning N, Carter AM, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
2. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
3. Elbaz A, Poirier O, Canaple S, Chedru F, Cambien F, Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.
4. Mansfield MW, Kohler HP, Arïëns RAS, McCormack LJ, Grant PJ. Circulation levels of coagulation factor XIII in subjects with type 2 diabetes and their first-degree relatives. Diabetes Care 2000; 23: 703-5.
5. Warner D, Mansfield MW, Grant PJ. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost 2001; 85: 408-11.
6. Warner D, Mansfield M, Grant PJ. Coagulation factor XIII levels in UK Asian subjects with type 2 diabetes mellitus and coronary artery disease. Thromb Haemost 2001; 86: 1117-8.
7. Mills JD, Mansfield MW, Grant PJ. Factor XHI-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease. Thromb Haemost 2002; 87: 409-14.
8. Kohler HP, Arïëns RAS, Mansfield MW, Whitaker P, Grant PJ. Factor XIII activity and antigen levels in patients with coronary artery disease. Thromb Haemost 2001; 85: 569-70.
9. Kohler HP, Arïëns RAS, Catto AJ, Carter AM, Miller GJ, Cooper JA, Mansfield MW, Standeven KF, Grant PJ. Factor XIII A-subunit con centration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men. Br J Haematol 2002; 118: 825-32.
10. Schroeder V, Chatterjee T, MehtaH, Windecker S, PhamT, Devantay N, Meier B, Kohler HP. Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angio-graphy. Thromb Haemost 2002; 88: 1020-5.
11. Arïëns RAS, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking and hypertension. Arterioscler Thromb Vase Biol 1999; 19: 2012-6.
12. Kohler HP, Ariens RAS, Whitaker P, Grant PJ. A common coding polymorphism in the factor XIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 1998; 80: 704.
13. Kangsadalampai S, Board PG. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 1998; 92: 2766-70.